Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest ...

Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest ...

Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...

About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater ...

Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid for ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

减重药物Ozempic的升级版 ...

After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the market opened Wednesday as its ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

This Score examines things like projected and historical earnings, sales, and cash flow to find stocks that will generate ...

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” third-quarter 2024 investor ...

The company narrowed its full-year guidance as its blockbuster weight-loss drug soars in popularity.